Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,6611,680 of 20,252 grants

Active NON-SBIR/STTR RPGS
Targeting circRNA translation in glioblastoma
NATIONAL CANCER INSTITUTE Greater Los Angeles Veterans Research an... United States 2024 – 2029

Project Summary Glioblastomas are highly malignant and invasive, making these neoplasms extremely difficult to surgically resect and these properties often result in tumors which a...

$3.14M
USD
Completed NON-SBIR/STTR RPGS
NPC1 as a novel therapeutic target in ccRCC
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Renal cell carcinoma (RCC) accounts for more than 430,000 cases of cancer worldwide and about 180,000 cancer-related deaths each year. Clear cell RCC (ccRC...

$2.2M
USD
Completed NON-SBIR/STTR RPGS
Linking lifestyles with tumor immune profiles to identify strategies for improving breast cancer outcomes
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2026

A developing body of preclinical evidence suggests that the integrity and composition of the tumor immune microenvironment (TIME) is highly plastic and is modulated by host lifesty...

$867.5K
USD
Completed NON-SBIR/STTR RPGS
Role of JMJD4 in Breast Cancer
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2026

PROJECT SUMMARY – ROLE OF JMJD4 IN BREAST CANCER In 2023, nearly 43,000 women will die from breast cancer in the US, indicating the urgent need for better therapies. A more compreh...

$725K
USD
Completed NON-SBIR/STTR RPGS
Cellular and Molecular Mechanisms of Arsenic-Induced Urothelial Bladder Cancer
NATIONAL CANCER INSTITUTE Dartmouth College United States 2024 – 2026

ABSTRACT Urothelial bladder cancer represents a significant global public health burden, accounting for some 200,000 deaths each year. Among the many environmental risk factors for...

$2.32M
USD
Completed NON-SBIR/STTR RPGS
Targeting Oxidized PTP1B for Anticancer Drug Discovery
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2024

PROJECT SUMMARY PTP1B, a non-receptor–type oncogenic PTP, also known as PTPN1, is involved in growth factor signaling. The PTP1B gene is frequently amplified in cancers and correla...

$373K
USD
Completed NON-SBIR/STTR RPGS
Explainable AI-Based Multi-Omics Analysis of Lung Cancer Health Disparity
NATIONAL CANCER INSTITUTE Florida International University United States 2024 – 2026

PROJECT SUMMARY The proposed research aims to understand and discover the disparity of lung cancer development between African Americans and European Americans, considering race an...

$1.68M
USD
Completed NON-SBIR/STTR RPGS
Identifying germline pathogenic variants in familial lung cancer among African-Americans
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2026

ABSTRACT Lung cancer (LC) is the third most common cancer in the U.S. with African Americans (AAs) having the highest incidence and mortality. While previous linkage, admixture, ex...

$800K
USD
Completed NON-SBIR/STTR RPGS
Human brain organoids as a novel platform for evaluating effects of radiation in the CNS and screening for radiation mitigators
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2026

PROJECT SUMMARY Radiation therapy (RT) is a standard-of-care oncological treatment for the central nervous system (CNS). However, during cranial RT, normal brain tissue adjacent to...

$786.7K
USD
Active NON-SBIR/STTR RPGS
Neuroprotection for chemotherapy induced peripheral neuropathy
NATIONAL CANCER INSTITUTE University of North Carolina Charlotte United States 2024 – 2027

Chemotherapy induced peripheral neuropathy (CIPN) poses a major clinical problem due to its oftentimes dose- limiting side effects associated with many commonly employed anti-cance...

$4.62M
USD
Completed NON-SBIR/STTR RPGS
CD28-KITv CAR T cells with PD-1 dominant negative receptor
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT ABSTRACT The success of chimeric antigen receptor (CAR) T-cell therapy in solid tumors requires antigen targets with no on-target, off-tumor toxicity, effective tumor infil...

$14.92M
USD
Active NON-SBIR/STTR RPGS
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2029

Summary Patients with extrabronchial tumors that induce malignant central airway obstruction (MCAO) face significant morbidity and only 1-7 months median overall survival. An estim...

$6.98M
USD
Active NON-SBIR/STTR RPGS
Interrogating MRCK Protein Kinases in Ovarian Cancer
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2029

The majority of recurrent ovarian cancers spread to the peritoneal cavity in the form of ascites, where tumor cells grow as spheroids, and metastasize to other organs causing morbi...

$4.52M
USD
Active NON-SBIR/STTR RPGS
Brain-Restricted Kinase Inhibition with Binary Pharmacology
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

Glioblastoma (GBM), the most common primary malignant brain cancer, remains among the most lethal of cancers. The mechanistic target of rapamycin (mTOR) is dysregulated prominently...

$6.71M
USD
Active NON-SBIR/STTR RPGS
Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

Summary Small cell lung cancer (SCLC) is a highly aggressive and lethal disease, accounting for about 15% of all lung cancers. SCLC patients often initially respond to chemotherapy...

$7.35M
USD
Active NON-SBIR/STTR RPGS
Molecular and cellular mechanisms of neuronal damage caused by anticancer therapies
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2029

Project Summary Cancer is a terrifying diagnosis, especially in a child, yet thanks to great advances in treatment, survival rates have increased steeply. For CNS/brain tumors and...

$6.38M
USD
Active NON-SBIR/STTR RPGS
Expanding the cancer paralog genetic interaction map to enable precision oncology
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Recent advances in targeted therapies have prolonged the survival of non-small cell lung cancer patients. However, lung cancer still remains the leading ca...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
A Topical Plasmid-based Approach to Cervical Cancer Screening
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The specific objective of this proposal is to demonstrate proof-of-concept for a novel screening approach for cervical cancer (CC) using a topically applie...

$2.06M
USD
Active NON-SBIR/STTR RPGS
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2026

SUMMARY Kinase inhibitors targeting the catalytic subunit of the DNA-dependent protein kinase (DNAPKcs) are being developed to sensitize tumors to clastogenic (chromosomal-breaking...

$369.7K
USD
Active NON-SBIR/STTR RPGS
Dietary fatty acids drive pancreatic cancer development
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Despite significant advances in cancer care, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death in the United States w...

$628.5K
USD